VRNA logo

Verona Pharma plc (VRNA) Free cash flow

annual FCF:

-$122.78M-$72.56M(-144.48%)
December 31, 2024

Summary

  • As of today (August 31, 2025), VRNA annual free cash flow is -$122.78 million, with the most recent change of -$72.56 million (-144.48%) on December 31, 2024.
  • During the last 3 years, VRNA annual FCF has fallen by -$89.52 million (-269.09%).
  • VRNA annual FCF is now -3611364.71% below its all-time high of $3400.00, reached on December 31, 2005.

Performance

VRNA Free cash flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherVRNAcash flow metrics

quarterly FCF:

$30.77M+$42.91M(+353.38%)
June 1, 2025

Summary

  • As of today (August 31, 2025), VRNA quarterly free cash flow is $30.77 million, with the most recent change of +$42.91 million (+353.38%) on June 1, 2025.
  • Over the past year, VRNA quarterly FCF has increased by +$47.55 million (+283.30%).
  • VRNA quarterly FCF is now at all-time high.

Performance

VRNA quarterly FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherVRNAcash flow metrics

TTM FCF:

-$73.44M+$47.55M(+39.30%)
June 1, 2025

Summary

  • As of today (August 31, 2025), VRNA TTM free cash flow is -$73.44 million, with the most recent change of +$47.55 million (+39.30%) on June 1, 2025.
  • Over the past year, VRNA TTM FCF has dropped by -$19.53 million (-36.21%).
  • VRNA TTM FCF is now -1534.20% below its all-time high of -$4.49 million, reached on March 31, 2017.

Performance

VRNA TTM FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherVRNAcash flow metrics

Free cash flow Formula

FCF = Cash From Operations − CAPEX

VRNA Free cash flow Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-144.5%+283.3%-36.2%
3 y3 years-269.1%+258.4%-159.3%
5 y5 years-186.1%+1098.6%-110.1%

VRNA Free cash flow Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-269.1%at lowat high+148.8%-159.3%+40.2%
5 y5-year-269.1%at lowat high+148.8%-359.6%+40.2%
alltimeall time<-9999.0%at lowat high+148.8%-1534.2%+40.2%

VRNA Free cash flow History

DateAnnualQuarterlyTTM
Jun 2025
-
$30.77M(-353.4%)
-$73.44M(-39.3%)
Mar 2025
-
-$12.14M(-58.1%)
-$121.00M(-1.5%)
Dec 2024
-$122.78M(+144.5%)
-$29.00M(-54.0%)
-$122.83M(+17.8%)
Sep 2024
-
-$63.07M(+275.7%)
-$104.25M(+93.4%)
Jun 2024
-
-$16.78M(+20.0%)
-$53.92M(-7.9%)
Mar 2024
-
-$13.98M(+34.2%)
-$58.56M(+16.2%)
Dec 2023
-$50.22M(-16.1%)
-$10.42M(-18.1%)
-$50.42M(+4.5%)
Sep 2023
-
-$12.73M(-40.6%)
-$48.23M(-9.4%)
Jun 2023
-
-$21.43M(+267.3%)
-$53.27M(+3.9%)
Mar 2023
-
-$5.83M(-29.2%)
-$51.26M(-14.4%)
Dec 2022
-$59.89M(+80.0%)
-$8.24M(-53.6%)
-$59.85M(-13.1%)
Sep 2022
-
-$17.76M(-8.5%)
-$68.90M(+143.2%)
Jun 2022
-
-$19.42M(+34.6%)
-$28.33M(-2.6%)
Mar 2022
-
-$14.43M(-16.5%)
-$29.08M(-12.6%)
Dec 2021
-$33.27M(-26.3%)
-$17.28M(-175.8%)
-$33.26M(+108.2%)
Sep 2021
-
$22.81M(-213.1%)
-$15.98M(-67.3%)
Jun 2021
-
-$20.17M(+8.3%)
-$48.93M(+53.7%)
Mar 2021
-
-$18.62M(+83.5%)
-$31.84M(-15.8%)
Dec 2020
-$45.16M(+5.2%)
-
-
Sep 2020
-
-$10.15M(+229.3%)
-$37.80M(+8.1%)
Jun 2020
-
-$3.08M(-76.7%)
-$34.96M(-17.6%)
Mar 2020
-
-$13.24M(+16.8%)
-$42.45M(+1.1%)
Dec 2019
-$42.92M
-$11.33M(+55.0%)
-$41.98M(+13.0%)
DateAnnualQuarterlyTTM
Sep 2019
-
-$7.31M(-30.8%)
-$37.14M(+24.0%)
Jun 2019
-
-$10.57M(-17.2%)
-$29.96M(+9.1%)
Mar 2019
-
-$12.76M(+96.6%)
-$27.47M(+16.9%)
Dec 2018
-$23.32M(-17.5%)
-$6.49M(+4798.9%)
-$23.48M(+0.5%)
Sep 2018
-
-$132.50K(-98.4%)
-$23.37M(-29.7%)
Jun 2018
-
-$8.08M(-8.0%)
-$33.22M(+5.7%)
Mar 2018
-
-$8.78M(+37.8%)
-$31.42M(+15.8%)
Dec 2017
-$28.26M(+300.9%)
-$6.37M(-36.2%)
-$27.13M(+30.7%)
Sep 2017
-
-$9.99M(+59.2%)
-$20.75M(+92.8%)
Jun 2017
-
-$6.27M(+39.6%)
-$10.77M(+139.6%)
Mar 2017
-
-$4.49M
-$4.49M
Dec 2016
-$7.05M(-26.8%)
-
-
Dec 2015
-$9.63M(+64.5%)
-
-
Dec 2014
-$5.85M(+64.2%)
-
-
Dec 2013
-$3.57M(-15.1%)
-
-
Dec 2012
-$4.20M(+69.0%)
-
-
Dec 2011
-$2.49M(-5.7%)
-
-
Dec 2010
-$2.64M(-0.9%)
-
-
Dec 2009
-$2.66M(+32.5%)
-
-
Dec 2008
-$2.01M(-17.1%)
-
-
Dec 2007
-$2.42M(+237.9%)
-
-
Dec 2006
-$717.10K(<-9900.0%)
-
-
Dec 2005
$3400.00
-
-

FAQ

  • What is Verona Pharma plc annual free cash flow?
  • What is the all time high annual FCF for Verona Pharma plc?
  • What is Verona Pharma plc annual FCF year-on-year change?
  • What is Verona Pharma plc quarterly free cash flow?
  • What is the all time high quarterly FCF for Verona Pharma plc?
  • What is Verona Pharma plc quarterly FCF year-on-year change?
  • What is Verona Pharma plc TTM free cash flow?
  • What is the all time high TTM FCF for Verona Pharma plc?
  • What is Verona Pharma plc TTM FCF year-on-year change?

What is Verona Pharma plc annual free cash flow?

The current annual FCF of VRNA is -$122.78M

What is the all time high annual FCF for Verona Pharma plc?

Verona Pharma plc all-time high annual free cash flow is $3400.00

What is Verona Pharma plc annual FCF year-on-year change?

Over the past year, VRNA annual free cash flow has changed by -$72.56M (-144.48%)

What is Verona Pharma plc quarterly free cash flow?

The current quarterly FCF of VRNA is $30.77M

What is the all time high quarterly FCF for Verona Pharma plc?

Verona Pharma plc all-time high quarterly free cash flow is $30.77M

What is Verona Pharma plc quarterly FCF year-on-year change?

Over the past year, VRNA quarterly free cash flow has changed by +$47.55M (+283.30%)

What is Verona Pharma plc TTM free cash flow?

The current TTM FCF of VRNA is -$73.44M

What is the all time high TTM FCF for Verona Pharma plc?

Verona Pharma plc all-time high TTM free cash flow is -$4.49M

What is Verona Pharma plc TTM FCF year-on-year change?

Over the past year, VRNA TTM free cash flow has changed by -$19.53M (-36.21%)
On this page